Pelvic exenteration for recurrent or advanced gynecologic malignancies – Analysis of outcome and complications

•Overall survival was 25.5% with a median follow-up of 47 months.•Positive resection margins had a negative impact on survival.•Neoadjuvant treatment correlated with achieving negative margins.•19% had no postoperative complications, major complications were observed in 40.4%